Rubber prices close lower: A note of caution amid weakness in commodities
智通财经2026/09/14 09:56- The Kuala Lumpur rubber market closed lower on Monday, following the weakening of regional rubber futures, while Japanese rubber futures extended their losing streak for the fourth consecutive trading day.
- Some traders noted that tire manufacturing in the region is slowing natural rubber procurement, further dampening market sentiment.
- Relevant data show that the operating rate of all-steel tire production has declined, with both month-on-month and year-on-year decreases.
- The rise in raw material costs has prompted some companies to maintain production controls, leading to reduced natural rubber purchases.
- Rising expectations of a Federal Reserve interest rate hike and concerns over the US economic outlook are also weighing on market confidence. After US consumer prices accelerated in August, market bets on a 25-basis-point hike in September increased, which could support the US dollar and drag down commodity prices.
- US consumer confidence worsened in September while inflation expectations rose, deepening concerns over consumer spending and economic activity.
- However, sharp rises in crude oil prices, along with the increased possibility of supply disruptions in major producing countries in Southeast Asia due to heavy rainfall and a strengthening El Niño expectation, partially cushioned the decline.
- As of publication, Brent crude was up 3.15% to $107.90 per barrel; SMR 20 rubber fell 22 sen to 976.5 sen per kilogram, and bulk latex dropped 2 sen to 710.5 sen per kilogram.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bayan Resources and its subsidiaries declare force majeure on coal supply agreements
MoffettNathanson raises SpaceX target price to $142
Survival Nearly Doubles! BioNTech (BNTX.US) Lung Cancer Candidate Drug PRESERVE-003 Achieves Success in Late-Stage Trial, Providing Critical Support for Oncology Transformation
BioNTech (BNTX.US) announced on Monday that a late-stage clinical trial demonstrated its candidate drug gotistobart provided a clinically meaningful overall survival benefit compared to standard therapy in a specific type of lung cancer.
Crypto prices
More
